| Wednesday, 31 May 2006: 8:30 AM-12:00 PM | |||
| Regency Ballroom A (Hyatt Regency Milwaukee) | |||
| Medicinal Chemistry (MEDI) | |||
| New Strategies for Modern Medicinal Chemistry I | |||
| Invited presentations in Medicinal Chemistry. Topics will include pharmaceutical drug discovery towards antiviral agents, cancer therapy, and neurological disorders. | |||
| Organizer: | Keith McDaniel | ||
| Presider: | Keith McDaniel | ||
| 8:30 AM | Introductory Remarks | ||
| 8:35 AM | 26 | Rational Drug Design. Where it has been and where might it go in the 21st Century Daniel H. Rich | |
| 9:20 AM | 27 | The search for the next generation of HIV protease inhibitors David A. DeGoey | |
| 10:05 AM | Break | ||
| 10:30 AM | 28 | The design of hepatitis C protease inhibitors and the discovery of VX-950 Robert B. Perni | |
| 11:15 AM | 29 | What molecular forces could possibly be involved in stabilizing the topoisomerase I-DNA-inhibitor ternary cleavage complex and what do the answers tell us about how to design more effective topoisomerase I inhibitors? Mark Cushman, Xiangshu Xiao, Alexandra Ioanoviciu, Andrew Morrell, Muthukaman Nagarajan, Yves Pommier, Smitha Antony, Glenda Kohlhagen, Christophe Marchand, Kurt W. Kohn, Bart L. Staker, Alex B. Burgin, Lance Stewart | |
Back to The 37th Great Lakes Regional Meeting (May 31- June 2, 2006)